Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
431.62
+1.52 (0.35%)
May 22, 2026, 3:44 PM EDT - Market open
Medpace Holdings Revenue
Medpace Holdings had revenue of $706.60M in the quarter ending March 31, 2026, with 26.50% growth. This brings the company's revenue in the last twelve months to $2.68B, up 24.19% year-over-year. In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth.
Revenue (ttm)
$2.68B
Revenue Growth
+24.19%
P/S Ratio
4.60
Revenue / Employee
$431,979
Employees
6,200
Market Cap
12.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 421.18M | 19.97% |
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.84M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.46M | 23.38% |
| Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
| Dec 31, 2019 | 860.97M | 156.38M | 22.19% |
| Dec 31, 2018 | 704.59M | 268.44M | 61.55% |
| Dec 31, 2017 | 436.15M | 14.57M | 3.46% |
| Dec 31, 2016 | 421.58M | 62.52M | 17.41% |
| Dec 31, 2015 | 359.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.63B |
| Labcorp Holdings | 14.14B |
| Quest Diagnostics | 11.28B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.39B |
| Mettler-Toledo International | 4.09B |
| Charles River Laboratories International | 4.03B |
| Revvity | 2.90B |
MEDP News
- 4 days ago - MEDP Fraud Notice: Medpace Sued for Securities Fraud after 16% Stock Drop -- Investors Reminded to Contact BFA Law by June 8 Case Deadline - GlobeNewsWire
- 9 days ago - Medpace Lawsuit Reminder: Investors with Losses after Company Discloses Cancellation Rates are Urged to Contact BFA Law before June 8 Deadline - NASDAQ:MEDP - GlobeNewsWire
- 15 days ago - MEDP Fraud News: Medpace Sued for Securities Fraud Over Cancellation Rates and 16% Stock Drop – Contact BFA Law if You Lost Money - Business Wire
- 4 weeks ago - Medpace price target lowered to $400 from $460 at BMO Capital - TheFly
- 4 weeks ago - Medpace price target lowered to $484 from $522 at RBC Capital - TheFly
- 4 weeks ago - Medpace price target lowered to $477 from $565 at Baird - TheFly
- 4 weeks ago - Medpace price target lowered to $450 from $500 at Barclays - TheFly
- 4 weeks ago - Medpace falls -22.4% - TheFly